March 27, 2019
Ipsen Publishes its 2018 Registration Document
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its 2018 Registration Document has been filed with the French…
Pharmaceuticals, Biotechnology and Life Sciences
Author: BusinessWire
March 27, 2019
ROTH Capital Partners Announces the Promotion of Yasmeen Rahimi, Ph.D.
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ROTH Capital Partners (“ROTH”), www.roth.com, a full service investment bank focused on serving emerging growth companies and…
March 27, 2019
Pharmacy Times Continuing Education™ to Host Directions in Pharmacy® Conference in California
The meeting will feature nationally and regionally recognized speakers sharing the latest insights into advancements in managing patients with chronic…
March 27, 2019
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets
Tel Aviv Sourasky Medical Center will conduct a safety and tolerability trial on OWC’s sublingual tablets for the treatment of…
March 27, 2019
Idiopathic Short Stature – 2019 Pipeline Insight Study – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Short Stature – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…
March 27, 2019
Neurofibromatoses – 2019 Pipeline Insight Study – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Neurofibromatoses – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights…
March 27, 2019
Immuno-Oncology Company Elicio Therapeutics Launches with Novel Vaccine & Immunotherapy Platform to Treat an Array of Cancers
$30 Million Financing Backing MIT-Developed Amphiphile Platform to Target a Wide-Range of Immunogens to the Lymph Nodes, the “Brain Center”…
March 27, 2019
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
Phase I Trial to Evaluate Safety and Immunogenicity of Engineered Envelope Protein NEW YORK–(BUSINESS WIRE)–The International AIDS Vaccine Initiative (IAVI)…
March 27, 2019
Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/RSV?src=hash” target=”_blank”gt;#RSVlt;/agt;–Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced…
March 27, 2019
Eureka Therapeutics Announces Publication of Preclinical Study Demonstrating GPRC5D as a Promising Target for Antibody-Based Therapies in Multiple Myeloma
Potential to target GPRC5D in multiple myeloma patients relapsed after BCMA-targeted therapy EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical stage…